I
INDIVIOR PLC ORDINARY SHARES
NASDAQ: INDV (Indivior PLC)
Kemas kini terakhir: semalam, 10:52AM31.34
-0.53 (-1.66%)
| Penutupan Terdahulu | 31.87 |
| Buka | 31.97 |
| Jumlah Dagangan | 1,823,143 |
| Purata Dagangan (3B) | 2,212,593 |
| Modal Pasaran | 3,912,921,088 |
| Harga / Pendapatan (P/E TTM) | 31.98 |
| Harga / Pendapatan (P/E Ke hadapan) | 12.30 |
| Harga / Jualan (P/S) | 2.55 |
| Harga / Buku (P/B) | 145.25 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Oct 2025 |
| Margin Keuntungan | -5.30% |
| Margin Operasi (TTM) | 25.56% |
| EPS Cair (TTM) | -0.050 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -6.30% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -23.00% |
| Nisbah Semasa (MRQ) | 0.880 |
| Aliran Tunai Operasi (OCF TTM) | 135.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 264.88 M |
| Pulangan Atas Aset (ROA TTM) | 12.60% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menaik | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menaik | Bercampur | |
| Stok | Indivior PLC | Menaik | Menaik |
AISkor Stockmoo
1.6
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.63 |
|
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 4.02% |
| % Dimiliki oleh Institusi | 89.09% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 41.00 (Piper Sandler, 30.82%) | Beli |
| Median | 35.00 (11.68%) | |
| Rendah | 34.00 (Craig-Hallum, 8.49%) | Beli |
| Purata | 36.67 (17.01%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 27.62 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 31 Oct 2025 | 41.00 (30.82%) | Beli | 29.37 |
| HC Wainwright & Co. | 30 Oct 2025 | 35.00 (11.68%) | Beli | 29.13 |
| Craig-Hallum | 27 Aug 2025 | 34.00 (8.49%) | Beli | 24.36 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Nov 2025 | Pengumuman | Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine |
| 30 Oct 2025 | Pengumuman | Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance |
| 28 Oct 2025 | Pengumuman | Indivior to Participate in the Stifel 2025 Healthcare Conference |
| 16 Oct 2025 | Pengumuman | Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th |
| 15 Oct 2025 | Pengumuman | Clinical Evidence Supports Rapid SUBLOCADE® Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment |
| 01 Oct 2025 | Pengumuman | Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation |
| 20 Aug 2025 | Pengumuman | Indivior to Participate in Upcoming Investor Events |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |